Clinical Trial Update: Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial update on immunosuppression withdrawal in stable pediatric liver transplant recipients; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant Recipients
• Liver Transplantation

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Liver Transplant Recipients, Liver Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2017-06-08